Create your myFindAPhD account
or sign up to myFindAPhD with
Sign up with FacebookAlready have a myFindAPhD Account? Log in
or continue with
Login with Facebook
About the Project
The World Health Organization (WHO) has declared antimicrobial drug resistance one of the greatest problems currently facing human health, and the situation is especially grave in the case of infections caused by bacterial pathogens. Compounding the issue, in the last 40 years only two structurally-novel antibacterial classes have been successfully developed for treating life-threatening bacterial infections.
The majority of our existing antibacterial armamentarium are microbial products; despite this, most antibacterial drug discovery programmes have abandoned the search for novel natural product antibiotics, favoring instead rational synthetic chemistry approaches which have yet to bear fruit.
The proposed studentship intends to utilize several innovative approaches to find and characterize novel antibiotic classes produced by micro-organisms, with a view to ultimately developing drugs active against multi-drug resistant bacterial pathogens such as Staphylococcus aureus and Pseudomonas aeruginosa.
The majority of our existing antibacterial armamentarium are microbial products; despite this, most antibacterial drug discovery programmes have abandoned the search for novel natural product antibiotics, favoring instead rational synthetic chemistry approaches which have yet to bear fruit.
The proposed studentship intends to utilize several innovative approaches to find and characterize novel antibiotic classes produced by micro-organisms, with a view to ultimately developing drugs active against multi-drug resistant bacterial pathogens such as Staphylococcus aureus and Pseudomonas aeruginosa.
References
Hawkey, P. M. (2008). The growing burden of antimicrobial resistance. Journal of Antimicrobial Chemotherapy, 62 (Supplement 1), i1-i9. doi: 10.1093/jac/dkn241.
Talbot, G. H., Bradley, J., Edwards Jr., J. E., Gilbert, D., Scheld, M., Bartlett, J. G., et al. (2006). Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin Infect Dis., 42 (5), 657-68.
Talbot, G. H., Bradley, J., Edwards Jr., J. E., Gilbert, D., Scheld, M., Bartlett, J. G., et al. (2006). Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin Infect Dis., 42 (5), 657-68.
Email Now
You haven’t included a message. Providing a specific message means universities will take your enquiry more seriously and helps them provide the information you need.
Why not add a message here
Why not add a message here
* required field
The information you submit to University of Leeds will only be used by them or their data partners to deal with your enquiry, according to their privacy notice. For more information on how we use and store your data, please read our privacy statement.
Search suggestions
Based on your current searches we recommend the following search filters.
Check out our other PhDs in Leeds, United Kingdom
Check out our other PhDs in United Kingdom
Start a New search with our database of over 4,000 PhDs
PhD suggestions
Based on your current search criteria we thought you might be interested in these.
Identification of novel accessory Sec components in bacteria using high-throughput methods
University of Birmingham
Towards the development of a novel class of broad-spectrum anti-infective drugs
University of Strathclyde
Novel Polycyclic Beta-lactams: New Antibiotics?
Loughborough University
